Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-05 21:11 | 2026-10-01 | BBNX | Beta Bionics, Inc. | Hopman Mark | Officer | SELL | $18.96 | 370 | $7,015 | 56,109 |
| 2026-10-05 21:54 | 2026-10-01 | SIBN | SI-BONE, Inc. | DUNN JEFFREY W | Director | OPT+S | $18.47 | 20,000 | $369,400 | 16,057 |
| 2026-10-05 20:40 | 2026-10-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Director, Officer, 10% owner | SELL | $9.05 | 29,653 | $268,330 | 6,092,819 |
| 2026-10-05 20:40 | 2026-10-01 | SGHT | Sight Sciences, Inc. | Badawi David | Director, Officer | SELL | $9.05 | 7,797 | $70,555 | 1,975,075 |
| 2026-10-05 20:42 | 2026-10-02 | SGHT | Sight Sciences, Inc. | Rodberg James | Officer | SELL | $8.85 | 7,208 | $63,812 | 216,829 |
| 2026-10-05 20:43 | 2026-10-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | Officer | SELL | $8.85 | 25,260 | $223,627 | 639,449 |
| 2026-10-05 20:43 | 2026-10-02 | SGHT | Sight Sciences, Inc. | Taylor Brenton | Officer | SELL | $8.85 | 2,988 | $26,453 | 261,990 |
| 2026-10-05 20:20 | 2026-10-01 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Officer | SELL | $9.44 | 150 | $1,416 | 50,919 |
| 2026-10-02 20:30 | 2026-10-01 | OBIO | Orchestra BioMed Holdings, Inc. | Sherman Darren | Director, Officer | SELL | $6.36 | 15,000 | $95,400 | 1,119,402 |
| 2026-10-03 00:24 | 2026-09-29 | XAIR | Beyond Air, Inc. | Lin Yi-Chien | 10% owner | BUY | $2.78 | 20,393 | $56,591 | 145,393 |
| 2026-10-01 22:00 | 2026-09-30 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | COHEN RAYMOND W | Director | SELL | $29.28 | 3,330 | $97,504 | 54,790 |
| 2026-10-01 21:35 | 2026-09-30 | CARL | CARLSMED, INC. | Bertolini Jeffrey | Officer | OPT+S | $13.99 | 243 | $3,400 | 22,489 |
| 2026-10-01 21:15 | 2026-09-30 | RDGL | VIVOS INC | Korenko Michael K | Director, Officer | BUY | $0.50 | 200,000 | $99,600 | 11,635,090 |
| 2026-09-30 21:20 | 2026-09-28 | STVN | Stevanato Group S.p.A. | Stocchi Mauro | Officer | SELL | $21.50 | 13,649 | $293,454 | 400,000 |
| 2026-09-30 20:15 | 2026-09-28 | DXCM | DEXCOM INC | Stern Sadie | Officer | SELL | $86.15 | 2,565 | $220,975 | 123,478 |
| 2026-09-30 01:13 | 2026-09-28 | BDX | BECTON DICKINSON & CO | Feld Michael | Officer | SELL | $183.70 | 76 | $13,961 | 19,644 |
| 2026-09-29 17:49 | 2026-09-28 | QTEX | QTREX Quantum Ltd. | Ben-Noon Dagi Shahar | Director, Officer | BUY | $0.71 | 168,894 | $119,543 | 3,646,133 |
| 2026-09-28 22:23 | 2026-09-25 | GKOS | GLAUKOS Corp | Navratil Tomas | Officer | SELL | $154.28 | 1,615 | $249,158 | 70,818 |
| 2026-09-25 14:51 | 2026-09-11 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | Director, Officer | BUY | $1.07 | 368,630 | $394,471 | 1,332,930 |
| 2026-09-24 21:00 | 2026-09-23 | ATRC | AtriCure, Inc. | Privitera Salvatore | Officer | SELL | $60.00 | 4,519 | $271,140 | 142,745 |
| 2026-09-23 22:04 | 2026-09-21 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Kwo Elizabeth | Director | SELL | $24.26 | 4,010 | $97,268 | 14,116 |
| 2026-09-23 21:40 | 2026-09-22 | BBNX | Beta Bionics, Inc. | Jones Christy | Director | SELL | $23.00 | 6,430 | $147,890 | 19,564 |
| 2026-09-23 19:52 | 2026-09-18 | OFIX | Orthofix Medical Inc. | Juniper Investment Company, LLC | 10% owner | BUY | $8.81 | 310,000 | $2,732,092 | 3,771,216 |
| 2026-09-22 20:26 | 2026-09-18 | OFIX | Orthofix Medical Inc. | Juniper Investment Company, LLC | 10% owner | SELL | $8.81 | 310,000 | $2,732,092 | 3,771,216 |
| 2026-09-21 22:19 | 2026-09-18 | HTFL | Heartflow, Inc. | Rogers Campbell | Officer | OPT+S | $50.15 | 19,682 | $987,052 | 79,956 |
| 2026-09-19 00:46 | 2026-09-17 | HTFL | Heartflow, Inc. | Verghese Vikram | Officer | SELL | $50.55 | 24,345 | $1,230,742 | 155,183 |
| 2026-09-18 23:51 | 2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Officer | SELL | $18.46 | 35,994 | $664,550 | 88,033 |
| 2026-09-18 21:32 | 2026-09-16 | GKOS | GLAUKOS Corp | Navratil Tomas | Officer | SELL | $166.92 | 1,457 | $243,204 | 72,433 |
| 2026-09-18 20:30 | 2026-09-16 | TELA | TELA Bio, Inc. | Capper Joseph H | Director | BUY | $1.18 | 75,000 | $88,793 | 179,827 |
| 2026-09-17 20:15 | 2026-09-16 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Officer | SELL | $22.00 | 2,650 | $58,300 | 177,390 |
| 2026-09-17 20:15 | 2026-09-16 | BBNX | Beta Bionics, Inc. | Hopman Mark | Officer | SELL | $20.13 | 30,779 | $619,640 | 56,479 |
| 2026-09-16 20:05 | 2026-09-14 | GUTS | FRACTYL HEALTH, INC. | BRADLEY WILLIAM | Director | BUY | $0.62 | 64,516 | $39,903 | 149,138 |
| 2026-09-16 20:26 | 2026-09-14 | DXCM | DEXCOM INC | AUGUSTINOS NICHOLAS | Director | SELL | $84.04 | 8,089 | $679,769 | 29,293 |
| 2026-09-16 20:25 | 2026-09-15 | DXCM | DEXCOM INC | Brown Michael Jon | Officer | SELL | $84.04 | 1,700 | $142,868 | 99,885 |
| 2026-09-16 22:46 | 2026-09-14 | TELA | TELA Bio, Inc. | Capper Joseph H | Director | BUY | $1.05 | 75,000 | $78,443 | 104,827 |
| 2026-09-16 21:30 | 2026-09-15 | CTSO | Cytosorbents Corp | Chan Phillip P. | Director, Officer | BUY | $6.00 | 3,774 | $22,644 | 100,996 |
| 2026-09-16 20:35 | 2026-09-15 | GMED | GLOBUS MEDICAL INC | TOBIN JAMES R | Director | OPT+S | $74.58 | 30,000 | $2,237,502 | 0 |
| 2026-09-16 20:05 | 2026-09-15 | CTSO | Cytosorbents Corp | Sobel Alan D. | Director | BUY | $6.10 | 2,500 | $15,254 | 9,887 |
| 2026-09-16 20:05 | 2026-09-14 | CTSO | Cytosorbents Corp | Capponi Vincent | Officer | BUY | $6.05 | 2,073 | $12,537 | 40,387 |
| 2026-09-16 15:41 | 2026-09-16 | RDGL | VIVOS INC | Weeks Brad Allan | Officer | BUY | $0.05 | 25,550 | $1,232 | 1,547,204 |
| 2026-09-15 20:15 | 2026-09-14 | BBNX | Beta Bionics, Inc. | Hopman Mark | Officer | SELL | $15.52 | 775 | $12,028 | 86,382 |
| 2026-09-15 20:03 | 2026-08-27 | PETV | PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% owner | BUY | $0.68 | 58,602 | $40,025 | 10,498,331 |
| 2026-09-15 23:44 | 2026-09-11 | HTFL | Heartflow, Inc. | Verghese Vikram | Officer | SELL | $50.08 | 34,975 | $1,751,611 | 179,528 |
| 2026-09-15 21:07 | 2025-07-24 | CARL | CARLSMED, INC. | Presidio Management Group XII, L.L.C. | 10% owner | BUY | $15.00 | 200,000 | $3,000,000 | 200,000 |
| 2026-09-15 20:34 | 2026-09-11 | MOBI | Mobia Medical, Inc. | Leavitt Chase C. | Officer | BUY | $10.30 | 2,000 | $20,600 | 5,000 |
| 2026-09-15 20:37 | 2026-09-11 | WST | WEST PHARMACEUTICAL SERVICES INC | Favorite Annette F | Officer | OPT+S | $355.03 | 7,524 | $2,671,260 | 21,818 |
| 2026-09-14 20:02 | 2026-09-10 | DXCM | DEXCOM INC | Sylvain Jereme M | Officer | SELL | $83.27 | 3,638 | $302,936 | 146,828 |
| 2026-09-15 00:23 | 2026-09-14 | SI | SHOULDER INNOVATIONS, INC. | Ball Robert Joseph | Director, Officer | OPT+S | $18.45 | 10,175 | $187,706 | 380,824 |
| 2026-09-14 23:30 | 2026-09-11 | PDEX | PRO DEX INC | Van Kirk Richard Lee Jr | Director, Officer | SELL | $59.36 | 765 | $45,412 | 79,228 |
| 2026-09-14 22:56 | 2026-09-11 | NVNO | enVVeno Medical Corp | Duhay Francis | Director | SELL | $11.21 | 11 | $123 | 2,351 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.